Wayne Joseph Riley - 28 Apr 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: Director
Issuer ticker: HCA
Reported as of: 28 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Apr 2026, 17:04:10 UTC
Prior SEC filing: 07 Aug 2025
Next SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Natalie Harrison Cline, Attorney-in-Fact

Key filing fact

Wayne Joseph Riley filed Form 4 for HCA Healthcare, Inc. (HCA) on 30 Apr 2026.

Key facts

This page summarizes Wayne Joseph Riley's Form 4 filing for HCA Healthcare, Inc. (HCA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Apr 2026, 17:04.

Change

Previous filing in this sequence was filed on 07 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001432895 Primary reporting owner

Riley Wayne Joseph

Relationship: Director
Address: ONE PARK PLAZA, NASHVILLE
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Signature date: 30 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Award

Transaction value
Shares: +509
Change %: +3.5%
Price: $0.000000^*
Shares after: 15,029
Date: 28 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.